Cargando…
Immunotherapy for Hepatocellular Carcinoma in the Setting of Liver Transplantation: A Review
The emerging field of immuno-oncology has brought exciting developments in the treatment of hepatocellular carcinoma (HCC). It has also raised urgent questions about the role of immunotherapy in the setting of liver transplantation, both before and after transplant. A growing body of evidence points...
Autores principales: | Lominadze, Zurabi, Hill, Kareen, Shaik, Mohammed Rifat, Canakis, Justin P., Bourmaf, Mohammad, Adams-Mardi, Cyrus, Abutaleb, Ameer, Mishra, Lopa, Shetty, Kirti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917203/ https://www.ncbi.nlm.nih.gov/pubmed/36768686 http://dx.doi.org/10.3390/ijms24032358 |
Ejemplares similares
-
Sump syndrome of the remnant common bile duct following a living donor liver transplant
por: Robbins, Gordon, et al.
Publicado: (2021) -
Constrictive Pericarditis as a Cause of Refractory Ascites
por: Lominadze, Zurabi, et al.
Publicado: (2015) -
Utilization of Immunotherapy for the Treatment of Hepatocellular Carcinoma in the Peri-Transplant Setting: Transplant Oncology View
por: Abdelrahim, Maen, et al.
Publicado: (2022) -
Use of Adjuvant Sorafenib in Liver Transplant Recipients with High-Risk Hepatocellular Carcinoma
por: Shetty, Kirti, et al.
Publicado: (2014) -
Gastric Pneumatosis in the Setting of Diabetic Ketoacidosis
por: Shaik, Mohammed Rifat, et al.
Publicado: (2023)